End-stage renal disease in developing countries
End-stage renal disease in developing countries
复制标题
DOI:
10.1046/j.1523-1755.2002.00426.x
复制
发表时间:
2002-07-01
影响因子:
19.6
通讯作者:
Singhal, M
中科院分区:
文献类型:
--
作者:
Kher, V;Singhal, M
Patient 1. A 24-year-old man, an unskilled worker in a small shop, was admitted with a two-day history of shortness of breath and altered sensorium. He had been admitted to a government hospital twice previously. The first time, 4 years earlier, he had edema and high blood pressure. The 24-hour protein excretion was 3.2 g; creatinine clearance, 26 mL/min; serum creatinine, 3.8 mg/dL; and blood urea, 100 mg/dL; ultrasound examination disclosed bilaterally small kidneys. A renal biopsy was not performed. He was given amlodipine, 10 mg twice daily; prazosin, 5 mg twice daily; and calcium carbonate, 500 mg three times daily with meals. He was advised to monitor his blood pressure and be monitored regularly. He did not comply with the advice.The second admission occurred six weeks ago, when he presented with advanced azotemia. He underwent two hemodialysis sessions through a double-lumen femoral catheter and was discharged and advised to continue hemodialysis as an outpatient and look for a kidney donor in the family. He defaulted until the current admission.